全文获取类型
收费全文 | 4234篇 |
免费 | 844篇 |
国内免费 | 140篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 67篇 |
妇产科学 | 56篇 |
基础医学 | 518篇 |
口腔科学 | 93篇 |
临床医学 | 423篇 |
内科学 | 672篇 |
皮肤病学 | 58篇 |
神经病学 | 473篇 |
特种医学 | 87篇 |
外国民族医学 | 4篇 |
外科学 | 498篇 |
综合类 | 231篇 |
现状与发展 | 2篇 |
预防医学 | 270篇 |
眼科学 | 32篇 |
药学 | 432篇 |
中国医学 | 63篇 |
肿瘤学 | 1221篇 |
出版年
2024年 | 9篇 |
2023年 | 179篇 |
2022年 | 142篇 |
2021年 | 519篇 |
2020年 | 437篇 |
2019年 | 403篇 |
2018年 | 316篇 |
2017年 | 309篇 |
2016年 | 318篇 |
2015年 | 460篇 |
2014年 | 384篇 |
2013年 | 469篇 |
2012年 | 281篇 |
2011年 | 227篇 |
2010年 | 175篇 |
2009年 | 131篇 |
2008年 | 114篇 |
2007年 | 89篇 |
2006年 | 70篇 |
2005年 | 46篇 |
2004年 | 27篇 |
2003年 | 28篇 |
2002年 | 29篇 |
2001年 | 16篇 |
2000年 | 7篇 |
1999年 | 9篇 |
1998年 | 3篇 |
1997年 | 4篇 |
1996年 | 5篇 |
1995年 | 2篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1990年 | 1篇 |
1989年 | 3篇 |
1980年 | 1篇 |
排序方式: 共有5218条查询结果,搜索用时 203 毫秒
1.
目的 通过分析特发性肺纤维化急性加重期(AE-IPF)患者证候与血清生物标志物的关系,为中医辨证治疗提供参考。方法 采用观察性研究设计,收集2019年3月至2019年11月三个中心的AE-IPF患者76例,其中痰热壅肺证26例、痰浊阻肺证50例,并纳入健康志愿者10例作为对照。采用ELISA测定患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平,分析与中医证候的相关性。结果 AE-IPF患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平均显著高于健康对照组。血清CCL18、HMGB1、KL-6、MMP-7和SP-D水平在痰热壅肺证和痰浊阻肺证患者间无显著性差异(P>0.05),而血清SP-A水平存在显著性差异(P<0.05)。结论 血清SP-A与AE-IPF证候存在一定的相关性,血清SP-A的浓度升高,与痰热壅肺证关系越密切,反之,血清SP-A浓度降低,则与痰浊阻肺证关系越密切。AE-IPF痰热壅肺证患者的预后可能较痰浊阻肺证患者更差。 相似文献
2.
3.
4.
5.
Tianyu Zeng Yijia Hua Chunxiao Sun Yuchen Zhang Fan Yang Mengzhu Yang Yiqi Yang Jun Li Xiang Huang Hao Wu Ziyi Fu Wei Li Yongmei Yin 《International journal of cancer. Journal international du cancer》2020,147(11):3007-3018
tRNA-derived fragments, a class of small noncoding RNAs (sncRNAs), have been identified in numerous studies in recent years. tRNA-derived fragments are classified into two main groups, including tRNA halves (tiRNAs) and tRNA-derived small RNA fragments (tRFs), according to different cleavage positions of the precursor or mature tRNAs. Instead of random tRNA degradation debris, a growing body of evidence has shown that tRNA-derived fragments are precise products of specific tRNA modifications and play important roles in biological activities, such as regulating protein translation, affecting gene expression, and altering immune signaling. Recently, the relations between tRNA-derived fragments and the occurrence of human diseases, especially cancers, have generated wide interest. It has been demonstrated that tRNA-derived fragments are involved in cancer cell proliferation, metastasis, progression and survival. In this review, we will describe the biogenesis of tRNA-derived fragments, the distinct expression and function of tRNA-derived fragments in the development of cancers, and their emerging roles as diagnostic and prognostic biomarkers and precise targets of future treatments. 相似文献
6.
目的:利用整合生物信息学手段分析EZH2(enhancer of zeste 2 polycomb repressive complex 2 subunit)基因在乳腺癌中的表达及其临床意义。方法:在肿瘤基因组计划数据库(The Cancer Genome Atlas,TCGA)中下载乳腺癌与正常乳腺组织的基因表达谱数据,进一步利用Ualcan数据库和人类蛋白质图谱(The Human Protein Atlas)数据库数据分析EZH2基因在乳腺癌中的mRNA及蛋白表达水平。利用Ualcan数据库分析EZH2基因的甲基化水平并筛选其共表达基因;对EZH2及其共表达基因进行GO(Gene Ontology)富集分析和KEGG通路分析以明确EZH2的共表达基因参与的生物学过程和相关通路;使用Kaplan-Meier生存分析法分析乳腺癌患者的总生存期、无病生存期、无远处转移生存期及后进展生存期与EZH2基因表达水平的关系并绘制生存曲线。结果:与正常乳腺组织相比,EZH2在乳腺癌组织中的mRNA及蛋白表达量明显升高。而EZH2的甲基化程度在乳腺癌组织与正常乳腺组织中则差异不明显。同时,EZH2的表达水平与年龄、乳腺癌分期及乳腺癌分子分型等因素密切相关。EZH2及其共表达基因主要参与了核碱基的调节、细胞周期调控、染色体分离、DNA复制、DNA修复等生物学过程,并参与了细胞周期、DNA 复制、M/G1期转化、M期、有丝分裂前中期、ATM通路等生物学通路。此外,EZH2基因表达水平高的乳腺癌患者的总生存期、无病生存期、无远处转移生存期及后进展生存期均明显低于EZH2基因低表达的患者。结论:EZH2在乳腺癌组织中高表达并且与患者不良预后密切相关。同时,EZH2的表达水平与乳腺癌的发生、发展密切相关。EZH2在乳腺癌诊断、靶向治疗及预后分析中具有重要的临床意义。 相似文献
7.
Cécile Vicier Lillian Werner Jonathan Chipman Lauren C. Harshman Dattatraya H. Patil Raina N. Fichorova Jennifer R. Rider Martin G. Sanda Lorelei A. Mucci Christopher J. Sweeney 《Clinical genitourinary cancer》2019,17(1):32-37
Background
Inflammation and infections have been associated with prostate cancer progression. We assessed whether elevated serum cytokines or T. vaginalis seropositivity at the time of diagnosis was associated with higher grade or lethal prostate cancer.Patients and Methods
Men with localized or metastatic prostate cancer were included in this study. Cytokine serum levels including interleukin (IL)-1α, IL-1β, IL-2, IL-6, IL-8, monocyte chemotactic protein 1 (CCL-2), tumor necrosis factor α, and growth-regulated oncogene α (CXCL-1) using a multiplex enzyme-linked immunosorbent assay and T. vaginalis serology were measured in blood samples at diagnosis.Results
A total of 324 patients were identified at time of localized disease and 118 at time of metastatic disease. Of the 189 patients with localized disease and clinical follow-up data (median, 73 months), 28 developed lethal disease. There was no association between circulating cytokine levels above median concentrations nor T. vaginalis seropositivity and risk of intermediate- to high-risk or lethal prostate cancer.Conclusion
Higher levels of serum cytokine levels and T. vaginalis seropositivity at diagnosis are not associated with high-grade or lethal prostate cancer and do not aid risk stratification of localized prostate cancer. 相似文献8.
《Clinical lung cancer》2020,21(5):e405-e414
BackgroundProgrammed cell death 1 (PD-1) inhibitors have become a standard treatment, albeit not completely effective, for patients with advanced non–small-cell lung cancer (NSCLC). Previous studies of advanced melanoma have revealed that the tumor burden predicted the response to PD-1 inhibitors, although this relationship has remained unclear for NSCLC.Patients and MethodsThe present single-center retrospective study evaluated 163 patients with advanced NSCLC who had received PD-1/programmed cell death ligand 1 (PD-L1) inhibitor monotherapy from December 2015 to December 2018. The clinical tumor burden was estimated using the baseline sum of the target lesions’ longest diameters (BSLDs), measured according to the Response Evaluation Criteria for Solid Tumors, and the baseline number of metastatic lesions (BNMLs).ResultsThe optimal cutoff values for predicting progression-free survival (PFS) were 5 for the BNMLs and 76 mm for the BSLDs, using the minimum P value method. The low-BNML group included 73 patients (44.8%). The median PFS was 12.2 months in the low-BNML group and 2.8 months in the high-BNML group (hazard ratio, 0.51; P = .0005). The low-BSLD group included 92 patients (56.4%). The median PFS was 9.6 months in the low-BSLD group and 3.4 months in the high-BSLD group (hazard ratio, 0.52; P = .0006). Multivariable analysis revealed that low-BSLD, low-BNML, nonsquamous histologic type and a PD-L1 tumor proportion score of ≥ 50% were independently associated with prolonged PFS.ConclusionsPD-L1 expression and the clinical tumor burden can predict the efficacy of PD-1/PD-L1 inhibitor monotherapy for NSCLC. 相似文献
9.
Metabolic abnormalities of gastrointestinal mucosa in celiac disease: An in vitro proton nuclear magnetic resonance spectroscopy study 下载免费PDF全文
10.
《Sleep medicine》2020
BackgroundNeurocognitive dysfunction and abnormal regional homogeneity (ReHo) have been reported in patients with obstructive sleep apnea (OSA). However, little is known about whether brain functional alteration could be used to differentiate from healthy controls (HCs) and its correlation with neurocognitive impairment.MethodsThirty-three treatment-naive patients with moderate-to-severe OSA and 22 HCs with matched age, sex and education underwent the evaluation of Epworth sleepiness scale, neurocognitive function, full night polysomnography and resting-state functional magnetic resonance imaging scan. ReHo, support vector machine, and correlation with neurocognitive function were administrated to analyze the data.ResultsCompared with HCs, patients with OSA showed decreased ReHo in the bilateral superior frontal gyrus (FG), bilateral superior medial prefrontal cortex (PFC)/right supplementary motor area (SMA), left middle FG, and right precentral/postcentral gyrus. Negative correlations were observed between the ReHo values in the left superior FG/middle FG and apnea hypopnea index, oxygen desaturation index in the OSA group. The scores of Stroop word test, Stroop color-word test, symbol coding test were all negatively correlated with the ReHo values in the right precentral gyrus/postcentral gyrus in patients. Scores of the animal naming fluency test were positively correlated with the ReHo values in the left superior FG/middle FG in patients. Moreover, support vector machine analysis showed the ReHo values in the left superior FG/middle FG or bilateral superior medial PFC/right SMA both could discriminate patients from HCs with good accuracies, sensitivities, and specificities (85.45%, 87.88%, 81.82% and 81.82%, 84.85%, 77.27%, respectively).ConclusionDysfunction in the frontal lobe is a potentially pivotal neuro-pathophysiological mechanism of neurocognitive impairment in patients with moderate-to-severe OSA. And significantly lower ReHo values in the left superior FG/middle FG and/or superior medial PFC/SMA are promising imaging biomarkers to discriminate moderate-to-severe patients with OSA from HCs. 相似文献